Exabis Library
Welcome to the e-CCO Library!
P629: Evolution of disease phenotype, time to biological therapy and medium-, long-term surgery rates in Crohn’s disease patients in Western Hungary – a population-based study between 2007–2018, data from the Veszprem county cohort
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P629: Impact of surgical treatment on quality of life in Crohn’s disease: Short-and longer-term follow-up
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P629: Real-life treatment persistence and treatment outcomes of Finnish patients with Inflammatory Bowel Disease receiving vedolizumab as first-line biological treatment
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P629: Rural-urban inequities in Inflammatory Bowel Disease health care access: a population-based retrospective cohort study from a Western Canadian Province
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P629: The initial trough concentration at 36 h after starting tacrolimus is important for the personalised medicine strategy in patients with ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P630 Complete endoscopic remission is not only associated with higher mucosal concentrations of 5-aminosalicylic acid but also with N-acetyl-5-aminosalicylic acid in patients with ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P630: A non-inferiority randomised clinical trial of the use of the smartphone-based health applications IBDsmart and IBDoc® in the care of inflammatory bowel disease patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P630: Development and evaluation of BioCLIA-Tracker infliximab kit: A fast and innovative chemiluminescent assay for the monitoring of patients treated with infliximab
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P630: Inflammatory bowel disease in immigrants to Spain: results of the EIIMIGRA study from GETECCU (ENEIDA registry)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P630: Systematic review and meta-analysis: Diagnostic delay and the subsequent impact on the disease course of adult Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P630: The long-term efficacy of adalimumab on Crohn's disease comorbid with perianal lesions and poor prognostic factor analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P630: Upadacitinib Improves Clinical Outcomes in Patients with Moderate to Severely Active Crohn's Disease Irrespective of Previous Failure to Respond to Biologics or Conventional Therapies
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P631 Predictors of vedolizumab treatment persistence in bio-naïve ulcerative colitis patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P631: Development and validation of a clinical scoring tool for predicting treatment outcomes with vedolizumab in patients with ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P631: Food triggers in inflammatory bowel disease from the patients’ and doctors’ perspective
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P631: Impact of Covid-19 pandemic on initiation of immunosuppressive treatment in immune-mediated diseases. -A nationwide, retrospective study-
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P631: Long-term safety of vedolizumab versus other biologic agents in ulcerative colitis (UC) and Crohn's Disease (CD): Results from a large multinational prospective observational study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P631: Results and predictors of outcome of endoscopic balloon dilation of colonic strictures in inflammatory bowel diseases
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P631: Treatment of established post-operative recurrence of Crohn’s disease with anti-TNF agents: Preliminary data of a multicentre, nationwide study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P632 Vedolizumab dose escalation in patients with inflammatory bowel disease experiencing loss of response: A systematic review and meta-analysis of real-world evidence
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM